Menu

Advancing Longevity Solutions, Powered by Research

Uniting expertise, capital, and innovation to scale breakthrough longevity solutions

Contact Us

Healthgevity Group combines deep research, strategic capital, and exceptional teams to unlock and scale breakthrough opportunities that advance the frontier of human longevity

Our Longevity Philosophy

We stand at an unprecedented inflection point in human healthspan and longevity. Five powerful forces are converging to transform how we understand, prevent, and treat age-related decline. From shifting global demographics to breakthrough scientific discoveries, from the revolution in personal health data to advances in AI-driven insights, these trends are creating extraordinary opportunities to reimagine healthcare. Moving from a reactive, disease-centric model to a preventative, personalized approach isn’t just possible – it’s inevitable. By understanding and harnessing these forces, Healthgevity Group aims to accelerate the transition to a new paradigm in human health and longevity.

Scientific Renaissance

Demographic Imperative

Healthcare Evolution

Data Revolution

Precision Longevity

Business Model Evolution +

The longevity sector is fostering new business models that unite researchers, clinicians, technology providers, and insurers. These models enable innovative payment systems, risk-sharing, and value-based partnerships, driving investment in preventative health solutions.

Service Innovation +

The convergence of data, technology, and personalized medicine is enabling novel service delivery models in preventative health and longevity optimization. These range from AI-driven health coaching to precision diagnostic services, creating new channels for intervention delivery and health management.

Therapeutic Expansion +

A proliferation of evidence-based interventions is emerging across multiple domains: novel pharmaceuticals, advanced diagnostics, digital health applications, and lifestyle optimization protocols. This multi-modal approach integrates traditional therapeutic pathways with emerging technologies and behavioral science.

Ecosystem Impacts +

The transformation of the longevity landscape is catalyzing changes across adjacent industries, from personalized nutrition to adaptive fitness solutions. This ripple effect is creating opportunities for established providers to evolve their offerings while enabling new entrants to address emerging needs.

 Our Vision

To accelerate humanity’s transition to a future where evidence-based longevity solutions are accessible, effective, and personalized.

 Our Mission

To identify, enable, and scale breakthrough longevity opportunities by uniting scientific research, strategic capital, and exceptional teams in the pursuit of transformative solutions.

Healthgevity Group's Vision

To accelerate humanity’s transition to a future where evidence-based longevity solutions are accessible, effective, and personalized.

Healthgevity Group's Mission

To identify, enable, and scale breakthrough longevity opportunities by uniting scientific research, strategic capital, and exceptional teams in the pursuit of transformative solutions.

About Us

Born from deep analysis of the longevity sector, Healthevity Group identifies and accelerates transformative opportunities through rigorous research and strategic orchestration. Our team combines expertise in scientific evaluation, market analysis, and entrepreneurship to unite the right partners – from top-caliber researchers and practitioners, to capital providers – in scaling breakthrough longevity solutions. We leverage our sophisticated understanding of emerging trends and our carefully curated global network to advance innovations that can meaningfully impact human healthspan.
 
 
 
Learn More

Announcement

01
To Be Announced
02
To Be Announced
03
To Be Announced
04
To Be Announced

Our Curated Latest in Longevity

4315

Coffee may protect people against irregular heartbeats, study finds

gene-therapy-body-produce-glp-1

Scientists Say They’ve Figured Out a Way to Reprogram the Pancreas to Produce GLP-1s Without Ozempic

4738

It sounds like witchcraft’: can light therapy really give you better skin, cleaner teeth, stronger joints?

6880

The plastic inside us: how microplastics may be reshaping our bodies and minds

nanoparticle-treatment-reverses-alzheimers-mice

Nanoparticle Treatment Reverses Alzheimer’s in Mice

d41586-025-02993-x_51450988

Which diseases will you have in 20 years? This AI accurately predicts your risks

This website and its content are copyright of Healthgevity Group, 2025.
Healthgevity Group is a is a trading name of Paradigm Change Capital Partners LLP, registered in England and Wales (OC356116), with registered offices at 21 Ellis Street, London SW1X 9AL, UK.

Navigation

Home
About Us
Longevity Resources
Contact Us

 

Stay In Touch

Scroll to Top

Scientific Renaissance

Recent advances in biotechnology, particularly in areas such as epigenetics and cellular reprogramming, are expanding our understanding of aging and disease mechanisms. The integration of AI and machine learning is accelerating research velocity, enabling rapid identification and validation of therapeutic targets and interventions. 

Demographic Imperative

Population aging is occurring across all developed and most developing nations, with the global share of people over 65 projected by UN DESA to rise to 1 in 6 people by 2050. This unprecedented demographic transition is reshaping healthcare demands and economic structures, creating substantial market opportunities for evidence-based longevity interventions.

Healthcare Evolution

Current healthcare systems built around treating diseases rather than preventing them, are becoming unsustainable. Skyrocketing costs and diminishing returns are driving a fundamental shift toward preventative, proactive approaches. Data indicates that transitioning to preventative models could significantly improve health outcomes while reducing long-term healthcare expenditures, presenting opportunities for systematic innovation.

Data Revolution

The widespread adoption of health monitoring technologies and biomarker tracking is generating unprecedented volumes of longitudinal health data. This biological data intersects with broader behavioral datasets—including location patterns, consumption habits, and lifestyle choices—creating rich, multi-dimensional insights into health determinants and outcomes. The convergence of these diverse data streams, combined with advanced analytics capabilities, enables deeper understanding of health trajectories and intervention efficacy.

Precision Longevity

Machine learning and AI are enabling us to analyze vast datasets to uncover individual patterns and personalized insights. This shift from a one-size-fits-all approach to precision diagnostics and interventions is revolutionizing how we understand and influence the aging process at an individual level.

  • Address: 21 Ellis Street, SW1X 9AL, London, UK
  • Phone: +44(0)20 8064 1425